Secondary Endpoint
SECONDARY
The study’s pre-specified secondary endpoint was the difference in BF-ADL upper limb score improvement from baseline to the end of the first month for patients in the TX arm versus the SOC arm in the mITT, with statistical significance evaluated using a two-sample t-test. BF-ADL upper limb scores for both arms were summarized using the mean and standard deviation.